Key result
In primary bovine hepatocytes, PNPLA3 protein abundance tended to decrease with fatty acid mixtures mimicking liver lipid accumulation and increased quadratically with mixtures mimicking liver lipid clearing.
Why the study?
The authors sought to determine whether PNPLA3 and other lipases, transcription factors, or FA-mediated genes are regulated by FA mimicking liver lipid accumulation, liver lipid clearing, or singular physiological FA in dairy cows.
p-value: p=0.04
Bovine PNPLA3 is translationally regulated by fatty acids, suggesting a potential mechanism for hepatic triglyceride clearing.
PNPLA3 knockdown raises TG in bovine hepatocytes; leaves open its therapeutic targeting in human steatosis.
Knockdown of patatin-like phospholipase domain-containing protein 3 (PNPLA3) increased triglycerides (TG) in primary bovine hepatocytes, suggesting that PNPLA3 plays a causal role in hepatic TG clearing. In vivo, PNPLA3 abundance across the periparturient period is inversely related to hepatic TG accumulation and circulating fatty acid (FA) concentrations. The purpose of this research was to determine if PNPLA3, as well as other lipases, transcription factors, or FA-mediated genes, are regulated by FA mimicking liver lipid accumulation (ACCUM) and liver lipid clearing (RECOV) or singular FA physiologically found in dairy cows at 0.5 mM of circulating RECOV (iRECOV). Abundance of PNPLA3 tended to decrease with ACCUM and increased quadratically with RECOV (P ≤ 0.10), differing from PNPLA3 expression, but consistent with previous in vivo research. Adipose TG lipase abundance, but not other lipase abundances, was quadratically responsive to both ACCUM and RECOV (P ≤ 0.005). Abundance of PNPLA3 and SREBP1c and expression of LXRA responded similarly to iRECOV, with C18:0 tending to decrease abundance (P ≤ 0.07). Results indicate that bovine PNPLA3 is translationally regulated by FA and although a LXRA-SREBP1c pathway mediation is possible, the mechanism warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Erb et al. (2022) studied Fatty liver syndrome (in vitro model) (n=4). Fatty acid mixtures (ACCUM and RECOV) and individual fatty acids (iRECOV) vs. Different concentrations and individual fatty acids was evaluated on PNPLA3 protein abundance (p=0.04). In primary bovine hepatocytes, PNPLA3 protein abundance tended to decrease with fatty acid mixtures mimicking liver lipid accumulation and increased quadratically with mixtures mimicking liver lipid clearing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: